サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1618957

神経刺激装置の世界市場：業界分析、規模、シェア、成長、動向、予測（2024年～2031年）

Neurostimulation Devices Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2031

出版日
ページ情報
英文 177 Pages
納期
2～5営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
神経刺激装置の世界市場：業界分析、規模、シェア、成長、動向、予測（2024年～2031年）
出版日: 2024年12月13日
発行: Persistence Market Research
ページ情報: 英文 177 Pages
納期: 2～5営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界の神経刺激装置の市場規模は、2024年に67億米ドルになるとみられ、2024年～2031年の予測期間に11.7%のCAGRで拡大し、2031年には146億米ドルに達すると予測されています。

神経刺激装置は、慢性疼痛、てんかん、パーキンソン病、うつ病など、さまざまな神経疾患や症状の治療に不可欠です。これらの機器は、神経系の特定部位に電気刺激を与え、神経活動を調節し、症状を緩和し、患者のQOLを向上させる。神経刺激装置市場は、脊髄刺激装置、脳深部刺激装置、迷走神経刺激装置などさまざまな装置を提供し、病院、診療所、在宅介護の現場に対応しています。市場成長の原動力は、神経疾患の有病率の増加、デバイス技術の進歩、効果的な治療手段としての神経刺激に対する認識の高まりです。

世界の神経刺激装置市場は、慢性疼痛や、てんかんやパーキンソン病などの神経疾患の罹患率の上昇など、いくつかの重要な要因によって推進されています。低侵襲な治療オプションに対する需要の高まりや、デバイスの小型化、充電式バッテリー、ワイヤレス接続の進歩により、患者の快適性が向上し、市場導入が拡大しています。さらに、老人人口の増加と医療費の増加が、効果的で長期的な神経学的治療に対する需要を促進しており、市場の成長をさらに促進しています。

神経刺激装置市場における大きな機会は、技術的進歩、用途の拡大、良好な人口動向から生じています。非侵襲的刺激技術、人工知能の統合、患者モニタリング機能の向上など、機器設計の革新が新たな可能性を引き出しています。肥満管理、脳卒中リハビリテーション、片頭痛治療などの症状における神経刺激の新たな応用が、市場の範囲を広げています。さらに、研究開発への投資の増加や業界各社の戦略的提携が、ダイナミックな神経刺激市場において成長と革新の道筋を作っています。

当レポートでは、世界の神経刺激装置市場について調査し、製品タイプ別、用途別、地域別動向、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場の範囲と定義
  • 市場力学
  • マクロ経済要因
  • COVID-19の影響分析
  • 予測要因- 関連性と影響

第3章 付加価値の洞察

  • 製品採用分析
  • 技術評価
  • 規制状況
  • バリューチェーン分析
  • 主要な取引と合併
  • PESTLE分析
  • ポーターのファイブフォース分析

第4章 価格動向分析、2019年～2031年

第5章 世界の神経刺激装置市場の見通し：実績（2019年～2023年）および予測（2024年～2031年）

  • 主なハイライト
  • 市場規模（10億米ドル）分析と予測
  • 世界の神経刺激装置市場の見通し：製品タイプ別
  • 世界の神経刺激装置市場の見通し：用途別
  • 市場の魅力分析：用途別
  • 世界の神経刺激装置市場の見通し：エンドユーザー別
  • 市場の魅力分析：エンドユーザー別

第6章 世界の神経刺激装置市場の見通し：地域別

  • 主なハイライト
  • 過去の市場規模（10億米ドル）と数量（台）の分析、地域別、2019年～2023年
  • 現在の市場規模（10億米ドル）と数量（台）の分析と予測、地域別、2023年～2031年
  • 市場の魅力分析：地域別

第7章 北米の神経刺激装置市場の見通し：実績（2019年～2023年）および予測（2024年～2031年）

第8章 欧州の神経刺激装置市場の見通し：実績（2019年～2023年）および予測（2024年～2031年）

第9章 東アジアの神経刺激装置市場の見通し：実績（2019年～2023年）および予測（2024年～2031年）

第10章 南アジアおよびオセアニアの神経刺激装置市場の見通し：実績（2019年～2023年）および予測（2024年～2031年）

第11章 ラテンアメリカの神経刺激装置市場の見通し：実績（2019年～2023年）および予測（2024年～2031年）

第12章 中東・アフリカの神経刺激装置市場の見通し：実績（2019年～2023年）および予測（2024年～2031年）

第13章 競合情勢

  • 市場シェア分析、2023年
  • 市場構造
  • 企業プロファイル（詳細- 概要、財務、戦略、最近の動向）
    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Cochlear Inc.
    • NDI Medical LLC
    • NeuroPace Inc.
    • MED-EL Medical Electronics
    • NeuroSigma Inc.

第14章 付録

目次
Product Code: PMRREP2824

Persistence Market Research has recently released a comprehensive report on the worldwide market for neurostimulation devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global neurostimulation devices market from 2024 to 2031.

Key Insights:

  • Neurostimulation Devices Market Size (2024E):US$ 6.7 Bn
  • Projected Market Value (2031F): US$ 14.6 Bn
  • Global Market Growth Rate (CAGR 2024 to 2031): 11.7%

Neurostimulation Devices Market - Report Scope:

Neurostimulation devices are critical in treating various neurological disorders and conditions, including chronic pain, epilepsy, Parkinson's disease, and depression. These devices deliver electrical stimulation to specific areas of the nervous system to modulate neural activity, alleviate symptoms, and improve patient quality of life. The neurostimulation devices market caters to hospitals, clinics, and homecare settings, offering a variety of devices such as spinal cord stimulators, deep brain stimulators, and vagus nerve stimulators. Market growth is driven by the increasing prevalence of neurological disorders, advancements in device technology, and growing awareness of neurostimulation as an effective treatment modality.

Market Growth Drivers:

The global neurostimulation devices market is propelled by several key factors, including the rising incidence of chronic pain and neurological disorders, such as epilepsy and Parkinson's disease. Increasing demand for minimally invasive treatment options and advancements in device miniaturization, rechargeable batteries, and wireless connectivity are enhancing patient comfort and expanding market adoption. Additionally, the growing geriatric population and increasing healthcare expenditure are driving the demand for effective and long-term neurological treatments, further fueling market growth.

Market Restraints:

Despite promising growth prospects, the neurostimulation devices market faces challenges, including high device costs, regulatory hurdles, and potential side effects associated with neurostimulation therapy. Limited access to advanced healthcare infrastructure in developing regions and the lengthy approval process for new devices can restrict market growth. Furthermore, reimbursement constraints and patient skepticism regarding device implantation present additional barriers to widespread adoption.

Market Opportunities:

Significant opportunities in the neurostimulation devices market stem from technological advancements, expanding applications, and favorable demographic trends. Innovations in device design, such as non-invasive stimulation techniques, artificial intelligence integration, and improved patient monitoring capabilities, are unlocking new potential. Emerging applications of neurostimulation in conditions like obesity management, stroke rehabilitation, and migraine treatment broaden the market scope. Moreover, increasing investments in R&D and strategic collaborations among industry players create pathways for growth and innovation in the dynamic neurostimulation landscape.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the neurostimulation devices market globally?
  • Which device types and applications are propelling neurostimulation adoption across various healthcare settings?
  • How are technological advancements shaping the competitive landscape of the neurostimulation devices market?
  • Who are the key players in the market, and what strategies are they employing to maintain competitiveness?
  • What are the emerging trends and future prospects in the global neurostimulation devices market?

Competitive Intelligence and Business Strategy:

Leading players in the global neurostimulation devices market, including Medtronic PLC, Boston Scientific Corporation, Abbott Laboratories, and Nevro Corp., focus on innovation and strategic partnerships to strengthen their market positions. These companies are investing heavily in R&D to develop advanced neurostimulation solutions, such as closed-loop systems, wearable stimulators, and devices with enhanced connectivity. Collaborations with healthcare providers, research institutions, and regulatory agencies enable market access and facilitate the adoption of cutting-edge technologies. Emphasis on patient education, clinical research, and evidence-based practice further supports market expansion and improved patient outcomes.

Key Companies Profiled:

  • Medtronic PLC
  • Boston Scientific Corporation
  • Abbott Laboratories
  • Nevro Corp.
  • LivaNova PLC
  • Cyberonics, Inc.
  • Stimwave LLC
  • NeuroPace, Inc.
  • Synapse Biomedical Inc.

Neurostimulation Devices Industry Segmentation

By Product Type

  • Spinal Cord Stimulators (SCS)
  • Deep Brain Stimulators (DBS)
  • Vagus Nerve Stimulators (VNS)
  • Sacral Nerve Stimulators
  • Transcranial Magnetic Stimulation (TMS) Devices
  • Transcutaneous Electrical Nerve Stimulation (TENS) Devices

By Application

  • Pain Management
  • Epilepsy
  • Depression
  • Parkinson's Disease

By End User

  • Hospitals
  • Clinics
  • Homecare Settings
  • Research Institutes

By Region

  • North America
  • Europe
  • Latin America
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Neurostimulation Devices Market Snapshot, 2024 and 2031
  • 1.2. Market Opportunity Assessment, 2024 - 2031, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Challenges
    • 2.2.5. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
    • 2.3.3. Global Healthcare Spending Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Technology Assessment
  • 3.3. Regulatory Landscape
  • 3.4. Value Chain Analysis
  • 3.5. Key Deals and Mergers
  • 3.6. PESTLE Analysis
  • 3.7. Porter's Five Force Analysis

4. Price Trend Analysis, 2019 - 2031

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product Type
  • 4.4. Regional Prices and Product Type Preferences

5. Global Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Bn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Bn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Bn) Analysis, 2019 - 2023
    • 5.2.2. Current Market Size (US$ Bn) Analysis and Forecast, 2024 - 2031
  • 5.3. Global Neurostimulation Devices Market Outlook: Product Type
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product Type, 2019 - 2023
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
      • 5.3.3.1. Spinal Cord Stimulators (SCS)
      • 5.3.3.2. Deep Brain Stimulators (DBS)
      • 5.3.3.3. Vagus Nerve Stimulators (VNS)
      • 5.3.3.4. Sacral Nerve Stimulators
      • 5.3.3.5. Transcranial Magnetic Stimulation (TMS) Devices
      • 5.3.3.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
    • 5.3.4. Market Attractiveness Analysis: Product Type
  • 5.4. Global Neurostimulation Devices Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) Analysis, By Application, 2019 - 2023
    • 5.4.3. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
      • 5.4.3.1. Pain Management
      • 5.4.3.2. Epilepsy
      • 5.4.3.3. Depression
      • 5.4.3.4. Parkinson's Disease
      • 5.4.3.5. Others
  • 5.5. Market Attractiveness Analysis: Application
  • 5.6. Global Neurostimulation Devices Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Bn) Analysis, By End User, 2019 - 2023
    • 5.6.3. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
      • 5.6.3.1. Hospitals
      • 5.6.3.2. Clinics
      • 5.6.3.3. Homecare Settings
      • 5.6.3.4. Research Institutes
  • 5.7. Market Attractiveness Analysis: End User

6. Global Neurostimulation Devices Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019 - 2023
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2023 - 2031
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Bn) and Analysis, By Market, 2019 - 2023
    • 7.2.1. By Country
    • 7.2.2. By Product Type
    • 7.2.3. By Application
    • 7.2.4. By End User
  • 7.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 7.4.1. Spinal Cord Stimulators (SCS)
    • 7.4.2. Deep Brain Stimulators (DBS)
    • 7.4.3. Vagus Nerve Stimulators (VNS)
    • 7.4.4. Sacral Nerve Stimulators
    • 7.4.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 7.4.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 7.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 7.5.1. Pain Management
    • 7.5.2. Epilepsy
    • 7.5.3. Depression
    • 7.5.4. Parkinson's Disease
    • 7.5.5. Others
  • 7.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 7.6.1. Hospitals
    • 7.6.2. Clinics
    • 7.6.3. Homecare Settings
    • 7.6.4. Research Institutes
  • 7.7. Market Attractiveness Analysis

8. Europe Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 8.3.1. By Country
    • 8.3.2. By Product Type
    • 8.3.3. By Application
    • 8.3.4. By End User
  • 8.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. U.K.
    • 8.4.4. Italy
    • 8.4.5. Spain
    • 8.4.6. Russia
    • 8.4.7. Turkey
    • 8.4.8. Rest of Europe
  • 8.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 8.5.1. Spinal Cord Stimulators (SCS)
    • 8.5.2. Deep Brain Stimulators (DBS)
    • 8.5.3. Vagus Nerve Stimulators (VNS)
    • 8.5.4. Sacral Nerve Stimulators
    • 8.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 8.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 8.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 8.6.1. Pain Management
    • 8.6.2. Epilepsy
    • 8.6.3. Depression
    • 8.6.4. Parkinson's Disease
    • 8.6.5. Others
  • 8.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 8.7.1. Hospitals
    • 8.7.2. Clinics
    • 8.7.3. Homecare Settings
    • 8.7.4. Research Institutes
  • 8.8. Market Attractiveness Analysis

9. East Asia Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 9.3.1. By Country
    • 9.3.2. By Product Type
    • 9.3.3. By Application
    • 9.3.4. By End User
  • 9.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 9.4.1. China
    • 9.4.2. Japan
    • 9.4.3. South Korea
  • 9.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 9.5.1. Spinal Cord Stimulators (SCS)
    • 9.5.2. Deep Brain Stimulators (DBS)
    • 9.5.3. Vagus Nerve Stimulators (VNS)
    • 9.5.4. Sacral Nerve Stimulators
    • 9.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 9.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 9.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 9.6.1. Pain Management
    • 9.6.2. Epilepsy
    • 9.6.3. Depression
    • 9.6.4. Parkinson's Disease
    • 9.6.5. Others
  • 9.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 9.7.1. Hospitals
    • 9.7.2. Clinics
    • 9.7.3. Homecare Settings
    • 9.7.4. Research Institutes
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 10.2.1. By Country
    • 10.2.2. By Product Type
    • 10.2.3. By Application
    • 10.2.4. By End User
  • 10.3. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 10.3.1. India
    • 10.3.2. SEA
    • 10.3.3. ANZ
  • 10.4. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 10.4.1. Spinal Cord Stimulators (SCS)
    • 10.4.2. Deep Brain Stimulators (DBS)
    • 10.4.3. Vagus Nerve Stimulators (VNS)
    • 10.4.4. Sacral Nerve Stimulators
    • 10.4.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 10.4.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 10.5. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 10.5.1. Pain Management
    • 10.5.2. Epilepsy
    • 10.5.3. Depression
    • 10.5.4. Parkinson's Disease
    • 10.5.5. Others
  • 10.6. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 10.6.1. Hospitals
    • 10.6.2. Clinics
    • 10.6.3. Homecare Settings
    • 10.6.4. Research Institutes

11. Latin America Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 11.3.1. By Country
    • 11.3.2. By Product Type
    • 11.3.3. By Application
    • 11.3.4. By End User
  • 11.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 11.4.1. Brazil
    • 11.4.2. Mexico
    • 11.4.3. Rest of Latin America
  • 11.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 11.5.1. Spinal Cord Stimulators (SCS)
    • 11.5.2. Deep Brain Stimulators (DBS)
    • 11.5.3. Vagus Nerve Stimulators (VNS)
    • 11.5.4. Sacral Nerve Stimulators
    • 11.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 11.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 11.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 11.6.1. Pain Management
    • 11.6.2. Epilepsy
    • 11.6.3. Depression
    • 11.6.4. Parkinson's Disease
    • 11.6.5. Others
  • 11.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 11.7.1. Hospitals
    • 11.7.2. Clinics
    • 11.7.3. Homecare Settings
    • 11.7.4. Research Institutes
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Neurostimulation Devices Market Outlook: Historical (2019 - 2023) and Forecast (2024 - 2031)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Historical Market Size (US$ Bn) Analysis, By Market, 2019 - 2023
    • 12.3.1. By Country
    • 12.3.2. By Product Type
    • 12.3.3. By Application
    • 12.3.4. By End User
  • 12.4. Current Market Size (US$ Bn) Analysis and Forecast, By Country, 2023 - 2031
    • 12.4.1. GCC Countries
    • 12.4.2. Egypt
    • 12.4.3. South Africa
    • 12.4.4. Northern Africa
    • 12.4.5. Rest of Middle East & Africa
  • 12.5. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product Type, 2023 - 2031
    • 12.5.1. Spinal Cord Stimulators (SCS)
    • 12.5.2. Deep Brain Stimulators (DBS)
    • 12.5.3. Vagus Nerve Stimulators (VNS)
    • 12.5.4. Sacral Nerve Stimulators
    • 12.5.5. Transcranial Magnetic Stimulation (TMS) Devices
    • 12.5.6. Transcutaneous Electrical Nerve Stimulation (TENS) Devices
  • 12.6. Current Market Size (US$ Bn) Analysis and Forecast, By Application, 2023 - 2031
    • 12.6.1. Pain Management
    • 12.6.2. Epilepsy
    • 12.6.3. Depression
    • 12.6.4. Parkinson's Disease
    • 12.6.5. Others
  • 12.7. Current Market Size (US$ Bn) Analysis and Forecast, By End User, 2023 - 2031
    • 12.7.1. Hospitals
    • 12.7.2. Clinics
    • 12.7.3. Homecare Settings
    • 12.7.4. Research Institutes
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. Medtronic
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Product Types
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Abbott
    • 13.3.3. Boston Scientific Corporation
    • 13.3.4. Cochlear Inc.
    • 13.3.5. NDI Medical LLC
    • 13.3.6. NeuroPace Inc.
    • 13.3.7. MED-EL Medical Electronics
    • 13.3.8. NeuroSigma Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations